Implantable Medical Devices Market Size By Product (Cardiovascular {Implantable Cardiac Defibrillators [ICDs], Stents, Pacemaker, Implantable Cardiac Monitors [ICM], Ventricular Assist Devices, Cardiac Resynchronization Therapy Devices [CRT]}, Orthopedic {Joint Reconstruction, Spinal Devices, Trauma Fixation Devices}, Ophthalmology {Intraocular Lenses and Glaucoma Implants}, Plastic Surgery {Breast Implants, Gluteal Implants}, Neurology {Deep Brain Stimulators}, Dental {Dental Implants, Dental Crowns and Abutment}), By Type (Diagnostic, Treatment), By Nature of Device (Active, Static/Non-active/Passive), By End-use (Hospitals, Multi-specialty Centres, Ambulatory Surgical Centers, Clinics), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Jan 2020  |  Report ID: GMI4483  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 250   |   Base Year: 2018




Summary Table of Contents Industry Coverage Methodology

Industry trends

Implantable Medical Devices Market size surpassed USD 90 billion in 2018 and is poised to grow at a CAGR of over 6.3% from 2019 to 2025. The market growth is driven by increasing incidence of organ failures due to chronic disorders and accidents.
 

Implantable Medical Devices Market

Get more details on this report - Request Free Sample PDF
 

Since first pacemaker implant in 1958, the implantable medical devices industry has made significant developments. From facing serious challenges such as material quality, battery durability, system delivery, functionality and wireless communication, the industry has advanced with adoption of microelectronics, biocompatible materials and sensor technology. The developmental history of implantable medical device reflects the development of power source, electronic technology, and related fields. Following the progress of the implantable medical devices in 1960 with the help of Greatbatch and co-workers, the first successful human transplant was done, wherein pacemakers were implanted successfully in about ten patients.
 

Later major medical device company such as Medtronic started collaborating with researches to make progress in implantable devices to the next level. Immense advancements have been made in devices such as deep brain stimulators, hip implants, breast implants, blood pressure sensors and several others to promote the proper functioning of the organs. In future, the industry will foresee significant breakthroughs, especially in active IMDs by incorporation of microelectro-mechanical systems and miniaturization that will ensure better treatment and outcome of fatal chronic disorders and disability.
 

Implantable Medical Devices Market Report Coverage
Report Coverage Details
Base Year: 2018 Market Size in 2018: 90.6 Billion (USD)
Historical Data for: 2014 to 2017 Forecast Period: 2019 to 2025
Forecast Period 2019 to 2025 CAGR: 6.3% 2025 Value Projection: 138.8 Billion (USD)
Pages: 250 Tables, Charts & Figures: 545
Geographies covered (19): U.S., Canada, Germany, UK, France, Italy, Spain, Russia, China, India, Japan, Australia, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, South Africa, UAE
Segments covered: Product, Type, Nature of Device, End-use and Region
Companies covered (20): Medtronic PLC, Zimmer Biomet, Allergan PLC, Teva Pharmaceutical Industries, Stryker Corporation, Smith & Nephew, Boston Scientific Corporation, Abbott Laboratories, Alcon Laboratories, Bausch & Lomb, Getinge AB, POLYTECH Health & Aesthetics, Nuvectra Corporation, Demant, Intersect ENT, Cochlear, W.L. Gore & Associates, Henry Schein, Biotronik, Johnson & Johnson
Growth Drivers:
  • Increasing incidence of chronic diseases across the globe
  • Scarcity of organ donors
  • Technological advancements in developed nations
  • Rising government funding for implantable medical devices in developed countries
  • Increasing focus on development of microelectronics and implantable sensors
  • Growing adoption of biomaterials for better biocompatibility and outcomes
Pitfalls & Challenges:
  • High cost of devices
  • Stringent regulations for active implantable medical devices
  • Considerable rate of post-procedural complications
  • High number of recalls of implantable medical devices

Get more details on this report - Request Free Sample PDF
 

Increasing number of accidents and injuries will offer lucrative growth opportunity for the implantable medical devices market

Every year numerous people are enhancing their life quality by undergoing surgical procedures involving implantation of medical devices. With an increase in age-related diseases, there has been a prolonged need of medical devices for better treatment of the chronic medical conditions. Moreover, rising incidence of chronic disorders, organ failures and scarcity of organ donors worldwide will augment the market demand. However, high cost associated with implantable medical devices and security and privacy concerns related to devices may hamper the market growth to a certain extent.
 

Orthopedic implant industry to progress rapidly in both developed and developing nations

Implantable Medical Devices Market Size By Product

Get more details on this report - Request Free Sample PDF
 

Orthopedic implantable medical devices market revenue was over USD 32 billion in 2018. Orthopedic segment consists of various implantable devices such as trauma fixation devices, spinal devices, joint reconstruction and others. The industry is working constantly to improve clinical outcomes of implantable medical devices. Rising prevalence of orthopedic disorders coupled with increasing geriatric population and road accidents will mark significant impact on the overall market expansion.
 

Recently people are undergoing total hip and knee replacement surgeries due to rise in bone fractures and injuries. Growing prevalence of osteoporosis, osteoarthritis and sports injuries are further boosting demand for orthopaedic implantable devices. Moreover, manufacturers are significantly investing in R&D to develop efficient devices, positively influencing the market size.
 

High-tech monitoring devices reduces the dependency of patients on family and medical caregivers

Diagnostic implantable medical devices market size valued around USD 700 million in 2018 due to increasing cases of chronic disorders such as cardiac disorders, obesity, diabetes due to sedentary lifestyle. Implantable medical devices such as blood pressure sensors and implantable loop recorders help the physicians and patients to monitor their illness to get an early update. These devices are wireless and automated, and they evaluate patient’s tolerance to drug dosage used for treatment. Adoption of advanced technology benefits associated with monitoring implantable devices for generating high-quality results will drive the market growth.
 

Growing demand for active implantable medical devices owing to rising need to treat serious neurological conditions

Active implantable medical devices market accounted for more than 23.5% revenue share in 2018. Active implantable medical devices include wide range of products such as pacemakers, infusion pumps, ventricular assists systems and defibrillators. Increasing cases of diseases such as Parkinson’s disease, spasticity, and other neurological conditions will fuel the market demand.
 

Commendable progress in treatment of paralysis patients using brain computer interface technology has been achieved with significant recovery of lost speech and mobility in patients. Furthermore, presence of advanced technology and rising prevalence of hypertension, diabetes mellitus and cardiac arrhythmia among others will aid the market size expansion over the coming years.
 

In context to providing improved healthcare to patients, multi-specialty centers play a vital role in impelling the number of implantations

Multi-speciality centres will witness a robust growth of over 6.3% during the forecast period. Multi-speciality centres offer specialized treatment to medical conditions that require advanced skills and technology. Better accessibility of implantable medical devices will foster the market value. Speciality centres provide better medical service, less medical complications, lower long-term cost and better outcomes. Rising incidence of cardiovascular, orthopaedic, and other chronic disorders will also impel the market growth of the multi-speciality centres.
 

Rapid adoption of state-of-the-art technology in implantable medical devices in North America

Implantable Medical Devices Market By Region   

Get more details on this report - Request Free Sample PDF
 

U.S. implantable medical devices market size is predicted to expand at 5.2% CAGR through 2025. Presence of major market players in the region and adoption of advanced technology for new product development will propel the market growth. Large number of leading players in the market are launching advanced implantable medical devices in the U.S. to effectively treat various chronic diseases. Also, significant increase in mortality rate due to cardiovascular and neurological disorders has played a major role in demand for implantable medical devices in the U.S.
 

Japan market is anticipated to register substantial growth between 2019 and 2025 led by adoption of sedentary lifestyle, rising geriatric population, huge investment in research and development activities. Elderly people are witnessing higher prevalence of osteoarthritis and orthopedic injuries requiring implantable orthopedic devices. In addition, presence of sophisticated medical facilities and rapid adoption of high-end technology will boost the market revenue in the country.
 

Market leaders are focusing on product innovation to strengthen implantable medical device portfolio

Some of the key players operating in the global implantable medical devices industry are Medtronic, Zimmer Biomet, Stryker, Johnson & Johnson, and Abbott. These market players are implementing various strategies such as new product launch, acquisitions, and collaborations, in order to capitalize high revenue share in the market.
 

Recent industry developments:

  • In October 2019, Medtronic received breakthrough device designation from FDA for fully implantable left ventricular assist device (LVAD) for patients with advanced heart failure. This designation will help the company to provide more effective treatment or diagnosis for life threatening disease, thereby expanding its business size. 
     
  • In January 2018, Zimmer Biomet announced FDA clearance of the Sidus Stem Free Shoulder System. The clearance helped the company in expanding its product portfolio, thus strengthening its market position.
     

The implantable medical devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2014 to 2025, for the following segments:
 

Market, by Product

  • Cardiovascular        
    • Pacemaker
    • Implantable cardiac defibrillators (ICDs)
    • Cardiac Resynchronization Therapy (CRT)
    • Stents
    • Ventricular assist devices
    • Implantable cardiac monitors (ICM)
    • Others
  • Orthopedic    
    • Joint Reconstruction
    • Trauma Fixation Devices
    • Spinal Devices
    • Others
  • Ophthalmology        
    • Intraocular Lenses and Glaucoma Implants
    • Others
  • Plastic surgery        
    • Breast Implants
    • Gluteal Implants
  • Neurology     
    • Deep Brain Stimulators
    • Others
  • Dental
    • Dental Implants
    • Dental Crowns and Abutment
    • Dental Brackets and Braces
    • Others
  • Others

Market, by Type

  • Diagnostic
  • Therapeutic

Market, by Nature of Device

  • Active
  • Passive/Non-active/Static

Market, by End-use

  • Hospitals
  • Multi-specialty Centers
  • Ambulatory Surgical Centers
  • Clinics
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
       

Frequently Asked Questions (FAQ) :

The market size of implantable medical devices surpassed USD 90 billion in 2018.
The industry share of implantable medical devices is poised to grow at a CAGR of over 6.3% from 2019 to 2025.
The U.S. market size is predicted to expand at 5.2% CAGR through 2025, according to the analysts at Global Market Insights, Inc.
Active implantable medical devices market accounted for more than 23.5% revenue share in 2018 owing to increasing cases of diseases such as Parkinson’s disease, spasticity, and other neurological conditions.
Some of the key players operating in the industry are Medtronic, Zimmer Biomet, Stryker, Johnson & Johnson, and Abbott.
The diagnostic implantable medical devices segment size will gain high traction due to increasing cases of chronic disorders such as cardiac disorders, obesity, diabetes due to sedentary lifestyle.

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Jan 2020
  • Pages: 250
  • Tables: 531
  • Charts / Figures: 14
  • Companies covered: 20
  • Countries covered: 19

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X